T&R Biofab Co Ltd is a Korea-based company mainly engaged in the production and sale of bioresorbable scaffolds. The bioresorbable scaffolds are sold under the name of T&R mesh and T&R Dental Mesh. In addition, the Company is involved in the production and sale of three Dimensions (3D) biodegradable polymer printing system, bioinks, 3D organoid and 3D cell therapies, among others. The bioinks are sold under the name of deCelluid. The Company distributes its products within the domestic market and to overseas markets.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change	Volume
26-06-19	2,070.00 ₩	-3.72%	259,352
26-06-18	2,150.00 ₩	-4.23%	171,725
26-06-17	2,245.00 ₩	+2.28%	354,433
26-06-16	2,195.00 ₩	+4.52%	122,565
26-06-15	2,100.00 ₩	-3.00%	127,545

End-of-day quote Korea S.E.

More quotes

Income Statement and Estimates

More financial data

End-of-day quote Korea S.E. Other stock markets 2026-06-19			5-day change	1st Jan Change
2,070.00 ^KRW	-3.72%		-4.39%	-47.06%

01-20	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
24-09-22	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI

Market Cap	98.67B 64.45M 56.2M 52.05M 48.72M 91.38M 6.08B 91.93M 617M 239M 2.99B 242M 237M 10.39B	P/E 2024	-12.2x	P/E 2025	-3.58x
Enterprise Value	120B 78.63M 68.56M 63.49M 59.44M 111M 7.42B 112M 753M 292M 3.65B 295M 289M 12.68B	EV / Sales 2024	25.1x	EV / Sales 2025	7.45x
Free-Float	82.77%	Yield 2024 *	-	Yield 2025	-

01-20	T&R Biofab's Q4 2025 Sales Jump 500%; Shares Decline 5%	MT
24-09-22	T&R Biofab Co., Ltd.(KOSDAQ:A246710) dropped from S&P Global BMI Index	CI
24-08-04	T&R Biofab Co., Ltd. announced that it has received KRW 7 billion in funding from BTC Investment	CI
24-07-22	T&R Biofab Co., Ltd. announced that it expects to receive KRW 7 billion in funding from BTC Investment and another investor	CI
24-07-03	T&R Biofab Co., Ltd. announced that it has received KRW 2.99999656 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
24-06-24	T&R Biofab Co., Ltd. announced that it expects to receive KRW 2.9999956 billion in funding from KB Securities Co.,Ltd, NH Investment & Securities Co., Ltd., Shinhan Bank, The Korea Securities Finance Corporation	CI
23-12-21	T&R Biofab Co., Ltd. announced that it has received KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
23-12-13	T&R Biofab Co., Ltd. announced that it expects to receive KRW 1.999996 billion in funding from Korea Investment Partners Co. Ltd., DreamCIS, Inc.	CI
23-10-18	CJ Foods Partners with T&R Biofab to Shape the Future of Food	CI
23-08-03	T&R Biofab Co., Ltd. announced that it has received KRW 24 billion in funding	CI
23-07-25	T&R Biofab Co., Ltd. announced that it expects to receive KRW 24 billion in funding	CI
23-05-14	T&R Biofab Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
21-09-20	T&R Biofab Co., Ltd.(KOSDAQ:A246710) added to S&P Global BMI Index	CI

1 day	-3.72%
1 week	-4.39%
Current month	+1.47%
1 month	-10.39%
3 months	-31.91%
6 months	-49.39%
Current year	-47.06%

T&R Biofab Co., Ltd. Stock

Stocks

A246710

KR7246710008

Medical Equipment, Supplies & Distribution

Valuation: T&R Biofab Co., Ltd.

Chart: T&R Biofab Co., Ltd.

Latest news : T&R Biofab Co., Ltd.

Quotes and Performance

Course Extremes

Managers and Directors: T&R Biofab Co., Ltd.

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Quotes

Income Statement and Estimates

1 week	2,010	2,395
1 month	1,957	2,495
Current year	1,957	4,800
1 year	1,127	4,925
3 years	1,127	11,575
5 years	1,127	37,916.67
10 years	1,127	37,916.67

Manager	Title	Age	Since
Won-Soo Yoon CEO	Chief Executive Officer	56	-
Young-Pil Kim DFI	Director of Finance/CFO	53	-
Ju-Sung Sim COO	Chief Operating Officer	56	-

Director	Title	Age	Since
Won-Soo Yoon BRD	Director/Board Member	56	-
Jin-Hyung Shin BRD	Director/Board Member	41	-
Song-Wan Jin BRD	Director/Board Member	51	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
25-03-05	Marinho Paulo Andre Nobrega	Others		3,392	0.0157%
25-03-05	Eun-kyung Cho	Others		15,492	0.0719%
25-02-25	Won-Soo Yoon	Buy	Chief Executive Officer	4,200	0.0195%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
T&R BIOFAB CO., LTD.	-3.72%	-4.39%	-50.71%	-81.38%	64.45M
STRYKER CORPORATION	+2.21%	-1.41%	-18.04%	+3.36%	118B
SMITH & NEPHEW PLC	-0.66%	-0.71%	+4.21%	-9.57%	12.63B
GLAUKOS CORPORATION	+2.57%	+3.05%	+30.48%	+96.25%	7.67B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.48%	-3.09%	-46.72%	-71.26%	4.07B
DOUBLE MEDICAL TECHNOLOGY INC.	+1.51%	+0.28%	+19.47%	+34.70%	2.55B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	+0.94%	-1.24%	-14.22%	-14.09%	1.77B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-0.21%	-4.06%	+4.27%	-21.68%	1.59B
L&C BIO CO.,LTD	+5.36%	+9.88%	+189.38%	+141.43%	1.49B
Average	+0.94%	+0.72%	+13.13%	+8.64%	16.65B
Weighted average by Cap.	+1.92%	+0.73%	-11.49%	+6.40%

	2024	2025
Net sales	4.87B 3.18M 2.78M 2.57M 2.41M 4.51M 300M 4.54M 30.5M 11.82M 148M 11.95M 11.69M 513M	26.97B 17.62M 15.36M 14.23M 13.32M 24.97M 1.66B 25.13M 169M 65.4M 818M 66.13M 64.71M 2.84B
Net income	-7.68B -5.02M -4.37M -4.05M -3.79M -7.11M -473M -7.15M -48.05M -18.62M -233M -18.83M -18.43M -809M	-34.94B -22.83M -19.9M -18.43M -17.26M -32.36M -2.15B -32.56M -219M -84.75M -1.06B -85.69M -83.85M -3.68B
Net Debt	28.78B 18.8M 16.39M 15.18M 14.21M 26.65M 1.77B 26.82M 180M 69.8M 873M 70.57M 69.06M 3.03B	21.7B 14.18M 12.36M 11.45M 10.72M 20.1M 1.34B 20.22M 136M 52.63M 658M 53.21M 52.07M 2.29B